ID   ARHGP_HUMAN             Reviewed;         580 AA.
AC   Q86VW2; A6NJH5; A9CQZ6; F8W7Z4; Q8WV84; Q96E63;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 2.
DT   07-APR-2021, entry version 156.
DE   RecName: Full=Rho guanine nucleotide exchange factor 25;
DE   AltName: Full=Guanine nucleotide exchange factor GEFT;
DE   AltName: Full=Rac/Cdc42/Rho exchange factor GEFT;
DE   AltName: Full=RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT;
DE   AltName: Full=p63RhoGEF;
GN   Name=ARHGEF25; Synonyms=GEFT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH CDC42
RP   AND RAC1, TISSUE SPECIFICITY, AND VARIANT TYR-253.
RX   PubMed=12547822; DOI=10.1074/jbc.m208896200;
RA   Guo X., Stafford L.J., Bryan B., Xia C., Ma W., Wu X., Liu D., Songyang Z.,
RA   Liu M.;
RT   "A Rac/Cdc42-specific exchange factor, GEFT, induces cell proliferation,
RT   transformation, and migration.";
RL   J. Biol. Chem. 278:13207-13215(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANT ARG-506.
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R.F., Ohara O.;
RT   "Human cDNA derived from mRNA for adult brain.";
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANTS
RP   TYR-253; ARG-397 AND ARG-506.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   LEU-301.
RX   PubMed=11861769;
RA   Souchet M., Portales-Casamar E., Mazurais D., Schmidt S., Leger I.,
RA   Javre J.L., Robert P., Berrebi-Bertrand I., Bril A., Gout B., Debant A.,
RA   Calmels T.P.;
RT   "Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor,
RT   is localized in cardiac sarcomere.";
RL   J. Cell Sci. 115:629-640(2002).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15069594; DOI=10.1007/s00210-004-0926-5;
RA   Lutz S., Freichel-Blomquist A., Rumenapp U., Schmidt M., Jakobs K.H.,
RA   Wieland T.;
RT   "p63RhoGEF and GEFT are Rho-specific guanine nucleotide exchange factors
RT   encoded by the same gene.";
RL   Naunyn Schmiedebergs Arch. Pharmacol. 369:540-546(2004).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH GNAQ AND GNA11.
RX   PubMed=15632174; DOI=10.1074/jbc.m411322200;
RA   Lutz S., Freichel-Blomquist A., Yang Y., Rumenapp U., Jakobs K.H.,
RA   Schmidt M., Wieland T.;
RT   "The guanine nucleotide exchange factor p63RhoGEF, a specific link between
RT   Gq/11-coupled receptor signaling and RhoA.";
RL   J. Biol. Chem. 280:11134-11139(2005).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH RHO-FAMILY SMALL GTPASES.
RX   PubMed=16314529; DOI=10.1128/mcb.25.24.11089-11101.2005;
RA   Bryan B.A., Mitchell D.C., Zhao L., Ma W., Stafford L.J., Teng B.B.,
RA   Liu M.;
RT   "Modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho
RT   family guanine nucleotide exchange factor GEFT.";
RL   Mol. Cell. Biol. 25:11089-11101(2005).
RN   [10]
RP   FUNCTION, INTERACTION WITH GNAQ, DOMAIN, REGION, AND MUTAGENESIS OF
RP   PHE-471; LEU-472; LEU-475; PRO-478 AND ILE-479.
RX   PubMed=17606614; DOI=10.1074/jbc.m703458200;
RA   Rojas R.J., Yohe M.E., Gershburg S., Kawano T., Kozasa T., Sondek J.;
RT   "Galphaq directly activates p63RhoGEF and Trio via a conserved extension of
RT   the Dbl homology-associated pleckstrin homology domain.";
RL   J. Biol. Chem. 282:29201-29210(2007).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 149-502.
RX   PubMed=18096806; DOI=10.1126/science.1147554;
RA   Lutz S., Shankaranarayanan A., Coco C., Ridilla M., Nance M.R., Vettel C.,
RA   Baltus D., Evelyn C.R., Neubig R.R., Wieland T., Tesmer J.J.;
RT   "Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the
RT   activation of RhoA by GPCRs.";
RL   Science 318:1923-1927(2007).
CC   -!- FUNCTION: May play a role in actin cytoskeleton reorganization in
CC       different tissues since its activation induces formation of actin
CC       stress fibers. It works as a guanine nucleotide exchange factor for Rho
CC       family of small GTPases. Links specifically G alpha q/11-coupled
CC       receptors to RHOA activation. May be an important regulator of
CC       processes involved in axon and dendrite formation. In neurons seems to
CC       be an exchange factor primarily for RAC1. Involved in skeletal
CC       myogenesis (By similarity). {ECO:0000250, ECO:0000269|PubMed:11861769,
CC       ECO:0000269|PubMed:12547822, ECO:0000269|PubMed:15069594,
CC       ECO:0000269|PubMed:15632174, ECO:0000269|PubMed:16314529,
CC       ECO:0000269|PubMed:17606614}.
CC   -!- SUBUNIT: Interacts (via the DH domain) with BVES (via the C-terminus
CC       cytoplasmic tail) (By similarity). Interacts with activated GNAQ and
CC       GNA11. Interacts with RHOA, CDC42 and RAC1. {ECO:0000250,
CC       ECO:0000269|PubMed:12547822, ECO:0000269|PubMed:15632174,
CC       ECO:0000269|PubMed:16314529, ECO:0000269|PubMed:17606614}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}. Cytoplasm,
CC       myofibril, sarcomere {ECO:0000269|PubMed:11861769}. Note=Highly
CC       colocalizes with actin regions.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q86VW2-1; Sequence=Displayed;
CC       Name=2; Synonyms=p63RhoGef;
CC         IsoId=Q86VW2-2; Sequence=VSP_031875;
CC       Name=3;
CC         IsoId=Q86VW2-3; Sequence=VSP_047254;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are highly expressed in
CC       excitable tissues, such as brain, heart and muscle. Also detected in
CC       kidney and liver. {ECO:0000269|PubMed:11861769,
CC       ECO:0000269|PubMed:12547822, ECO:0000269|PubMed:15069594}.
CC   -!- DOMAIN: The guanine nucleotide exchange activity is autoinhibited by
CC       the PH domain. {ECO:0000269|PubMed:17606614}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF487514; AAO49463.2; -; mRNA.
DR   EMBL; AB370196; BAF94999.1; -; mRNA.
DR   EMBL; AC025165; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97037.1; -; Genomic_DNA.
DR   EMBL; BC012860; AAH12860.1; -; mRNA.
DR   EMBL; BC018536; AAH18536.1; -; mRNA.
DR   EMBL; BC047559; AAH47559.1; -; mRNA.
DR   CCDS; CCDS44931.1; -. [Q86VW2-3]
DR   CCDS; CCDS8947.1; -. [Q86VW2-1]
DR   RefSeq; NP_001104740.1; NM_001111270.2. [Q86VW2-3]
DR   RefSeq; NP_001334862.1; NM_001347933.1.
DR   RefSeq; NP_891992.2; NM_182947.3. [Q86VW2-1]
DR   PDB; 2RGN; X-ray; 3.50 A; B/E=149-502.
DR   PDBsum; 2RGN; -.
DR   SMR; Q86VW2; -.
DR   BioGRID; 125438; 24.
DR   CORUM; Q86VW2; -.
DR   IntAct; Q86VW2; 7.
DR   STRING; 9606.ENSP00000335560; -.
DR   iPTMnet; Q86VW2; -.
DR   PhosphoSitePlus; Q86VW2; -.
DR   SwissPalm; Q86VW2; -.
DR   BioMuta; ARHGEF25; -.
DR   DMDM; 172046695; -.
DR   jPOST; Q86VW2; -.
DR   MassIVE; Q86VW2; -.
DR   PaxDb; Q86VW2; -.
DR   PeptideAtlas; Q86VW2; -.
DR   PRIDE; Q86VW2; -.
DR   ProteomicsDB; 30042; -.
DR   ProteomicsDB; 70082; -. [Q86VW2-1]
DR   ProteomicsDB; 70083; -. [Q86VW2-2]
DR   Antibodypedia; 34950; 66 antibodies.
DR   Ensembl; ENST00000286494; ENSP00000286494; ENSG00000240771. [Q86VW2-1]
DR   Ensembl; ENST00000333972; ENSP00000335560; ENSG00000240771. [Q86VW2-3]
DR   Ensembl; ENST00000616622; ENSP00000484303; ENSG00000240771. [Q86VW2-2]
DR   GeneID; 115557; -.
DR   KEGG; hsa:115557; -.
DR   UCSC; uc001spa.5; human. [Q86VW2-1]
DR   CTD; 115557; -.
DR   DisGeNET; 115557; -.
DR   GeneCards; ARHGEF25; -.
DR   HGNC; HGNC:30275; ARHGEF25.
DR   HPA; ENSG00000240771; Low tissue specificity.
DR   MIM; 610215; gene.
DR   neXtProt; NX_Q86VW2; -.
DR   OpenTargets; ENSG00000240771; -.
DR   VEuPathDB; HostDB:ENSG00000240771.6; -.
DR   eggNOG; KOG0689; Eukaryota.
DR   GeneTree; ENSGT00940000160422; -.
DR   HOGENOM; CLU_001356_6_0_1; -.
DR   InParanoid; Q86VW2; -.
DR   OMA; GRCACPH; -.
DR   OrthoDB; 301115at2759; -.
DR   PhylomeDB; Q86VW2; -.
DR   TreeFam; TF318080; -.
DR   PathwayCommons; Q86VW2; -.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   SIGNOR; Q86VW2; -.
DR   BioGRID-ORCS; 115557; 11 hits in 993 CRISPR screens.
DR   EvolutionaryTrace; Q86VW2; -.
DR   GeneWiki; GEFT; -.
DR   GenomeRNAi; 115557; -.
DR   Pharos; Q86VW2; Tbio.
DR   PRO; PR:Q86VW2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q86VW2; protein.
DR   Bgee; ENSG00000240771; Expressed in esophagus and 191 other tissues.
DR   ExpressionAtlas; Q86VW2; baseline and differential.
DR   Genevisible; Q86VW2; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030016; C:myofibril; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030017; C:sarcomere; IEA:UniProtKB-SubCell.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR030738; ARHGEF25.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   PANTHER; PTHR22826:SF117; PTHR22826:SF117; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cytoplasm;
KW   Guanine-nucleotide releasing factor; Membrane; Reference proteome.
FT   CHAIN           1..580
FT                   /note="Rho guanine nucleotide exchange factor 25"
FT                   /id="PRO_0000322132"
FT   DOMAIN          160..336
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          348..466
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          278..299
FT                   /note="Important for binding to Rho GTPases"
FT   REGION          467..493
FT                   /note="Sufficient to bind activated GNAQ"
FT   VAR_SEQ         1..106
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_031875"
FT   VAR_SEQ         1..32
FT                   /note="MRGGHKGGRCACPRVIRKVLAKCGCCFARGGR -> MKPPDRPAPGRTDRIL
FT                   GVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDREHEVLAGALQP (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_047254"
FT   VARIANT         253
FT                   /note="C -> Y (in dbSNP:rs17857333)"
FT                   /evidence="ECO:0000269|PubMed:12547822,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_039402"
FT   VARIANT         397
FT                   /note="G -> R (in dbSNP:rs17854492)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_039403"
FT   VARIANT         506
FT                   /note="Q -> R (in dbSNP:rs1564374)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.2"
FT                   /id="VAR_039404"
FT   MUTAGEN         301
FT                   /note="L->E: Abolishes its exchange activity on RHOA."
FT                   /evidence="ECO:0000269|PubMed:11861769"
FT   MUTAGEN         471
FT                   /note="F->A: Reduces exchange activity mediated by GNAQ
FT                   activation; in truncated construct."
FT                   /evidence="ECO:0000269|PubMed:17606614"
FT   MUTAGEN         472
FT                   /note="L->A: Reduces exchange activity mediated by GNAQ
FT                   activation; in truncated construct."
FT                   /evidence="ECO:0000269|PubMed:17606614"
FT   MUTAGEN         475
FT                   /note="L->A: Reduces exchange activity mediated by GNAQ
FT                   activation; in truncated construct."
FT                   /evidence="ECO:0000269|PubMed:17606614"
FT   MUTAGEN         478
FT                   /note="P->A: Reduces exchange activity mediated by GNAQ
FT                   activation; in truncated construct."
FT                   /evidence="ECO:0000269|PubMed:17606614"
FT   MUTAGEN         479
FT                   /note="I->A: Reduces exchange activity mediated by GNAQ
FT                   activation; in truncated construct."
FT                   /evidence="ECO:0000269|PubMed:17606614"
FT   HELIX           151..154
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           156..183
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           186..193
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   STRAND          197..199
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           200..202
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           203..207
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           210..219
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           221..229
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           232..234
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           235..241
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   TURN            242..246
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           247..254
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           257..263
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   TURN            264..266
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           268..278
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           284..287
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           290..295
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           298..308
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   STRAND          310..312
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           316..338
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           339..341
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   STRAND          355..364
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   STRAND          378..393
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   STRAND          406..413
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           414..416
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   STRAND          417..422
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           423..425
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   STRAND          429..435
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   STRAND          437..439
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   STRAND          441..450
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           451..475
FT                   /evidence="ECO:0007744|PDB:2RGN"
FT   HELIX           478..489
FT                   /evidence="ECO:0007744|PDB:2RGN"
SQ   SEQUENCE   580 AA;  63843 MW;  F3EC80445D965BFB CRC64;
     MRGGHKGGRC ACPRVIRKVL AKCGCCFARG GRESYSIAGS EGSISASAAS GLAAPSGPSS
     GLSSGPCSPG PPGPVSGLRR WLDHSKHCLS VETEADSGQA GPYENWMLEP ALATGEELPE
     LTLLTTLLEG PGDKTQPPEE ETLSQAPESE EEQKKKALER SMYVLSELVE TEKMYVDDLG
     QIVEGYMATM AAQGVPESLR GRDRIVFGNI QQIYEWHRDY FLQELQRCLK DPDWLAQLFI
     KHERRLHMYV VYCQNKPKSE HVVSEFGDSY FEELRQQLGH RLQLNDLLIK PVQRIMKYQL
     LLKDFLKYYN RAGMDTADLE QAVEVMCFVP KRCNDMMTLG RLRGFEGKLT AQGKLLGQDT
     FWVTEPEAGG LLSSRGRERR VFLFEQIIIF SEALGGGVRG GTQPGYVYKN SIKVSCLGLE
     GNLQGDPCRF ALTSRGPEGG IQRYVLQAAD PAISQAWIKH VAQILESQRD FLNALQSPIE
     YQRRESQTNS LGRPRGPGVG SPGRIQLGDQ AQGSTHTPIN GSLPSLLLSP KGEVARALLP
     LDKQALGDIP QAPHDSPPVS PTPKTPPCQA RLAKLDEDEL
//
